title: Adenosine and its receptors as therapeutic targets: An overview.
abstract: The main goal of the authors is to present an overview of adenosine and its receptors, which are G-protein coupled receptors. The four known adenosine receptor subtypes are discussed along with the therapeutic potential indicating that these receptors can serve as targets for various dreadful diseases.
authors: ASBASJSM College of Pharmacy, Bela, Ropar, India.
authors: Sakshi
authors: S
authors: Sachdeva
authors: Monika
authors: M
authors: Gupta
keywords: A1, A2A, A2B, A3 receptors; Adenosine; Purine ribonucleosides
references: FASEB J. 1995 Mar;9(5):359-65
references: 7896004
references: Blood. 2003 Dec 15;102(13):4472-8
references: 12947007
references: Inflamm Res. 2004 May;53(5):171-8
references: 15105965
references: Circ Res. 1991 Dec;69(6):1583-90
references: 1659504
references: Trends Pharmacol Sci. 1994 Aug;15(8):298-306
references: 7940998
references: Bioorg Med Chem Lett. 2005 Mar 1;15(5):1333-6
references: 15713381
references: Pharmacol Biochem Behav. 2012 Jan;100(3):498-505
references: 22037410
references: Neurology. 2003 Aug 12;61(3):286-7
references: 12913183
references: J Infect Dis. 2004 May 15;189(10):1897-904
references: 15122527
references: Annu Rev Pharmacol Toxicol. 1995;35:581-606
references: 7598508
references: Eur J Med Chem. 2003 Apr;38(4):367-82
references: 12750024
references: Pharmacol Ther. 2011 Dec;132(3):280-99
references: 21810444
references: Neoplasia. 2008 Sep;10(9):987-95
references: 18714400
references: Curr Top Med Chem. 2003;3(4):413-26
references: 12570759
references: Mini Rev Med Chem. 2005 Dec;5(12):1053-60
references: 16375751
references: Curr Pharm Des. 2004;10(17):2021-39
references: 15279543
references: J Pharmacol Exp Ther. 1997 Jan;280(1):301-9
references: 8996210
references: Bioorg Med Chem. 2004 Feb 1;12(3):613-23
references: 14738972
references: Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jun;30(4):617-29
references: 16580767
references: Curr Drug Targets. 2006 Jun;7(6):699-706
references: 16787172
references: Chem Rev. 2008 Jan;108(1):238-63
references: 18181659
references: Retrovirology. 2008 Mar 28;5:30
references: 18373845
references: J Med Chem. 2010 May 13;53(9):3748-55
references: 20405927
references: Circulation. 2005 Jun 21;111(24):3202-8
references: 15956124
references: Expert Opin Ther Pat. 2012 Apr;22(4):369-90
references: 22435652
references: Br J Pharmacol. 1978 May;63(1):125-38
references: 25686
references: Genomics. 1995 Mar 20;26(2):423-5
references: 7601478
references: Pharmacol Ther. 2001 Aug;91(2):133-47
references: 11728606
references: Curr Opin Pharmacol. 2009 Aug;9(4):501-6
references: 19539527
references: Neuropharmacology. 2012 Mar;62(4):1756-66
references: 22182780
references: Pharmacol Res. 2012 Jan;65(1):81-90
references: 21933714
references: Curr Top Med Chem. 2003;3(4):369-85
references: 12570756
references: Mol Pharmacol. 2005 May;67(5):1385-7
references: 15703375
references: Invest Ophthalmol Vis Sci. 2002 Sep;43(9):3021-6
references: 12202525
references: Med Res Rev. 2006 Mar;26(2):131-59
references: 16380972
references: Int Immunopharmacol. 2007 Apr;7(4):483-90
references: 17321471
references: Mol Pharmacol. 1970 Jan;6(1):13-23
references: 4354003
references: J Physiol. 1929 Nov 25;68(3):213-37
references: 16994064
references: Bioorg Med Chem. 1998 Jun;6(6):619-41
references: 9681130
references: Ann Intern Med. 1997 Sep 15;127(6):417-22
references: 9312997
references: Neuropharmacology. 2012 Mar;62(3):1527-43
references: 21315743
references: Pharmacol Ther. 2009 Jul;123(1):105-16
references: 19426761
references: J Med Chem. 2009 Jul 9;52(13):3994-4006
references: 19569717
references: J Clin Invest. 2006 Jul;116(7):1913-23
references: 16823489
references: Purinergic Signal. 2008 Dec;4(4):305-12
references: 18438720
references: Bioorg Med Chem Lett. 2008 Mar 15;18(6):1778-83
references: 18329269
references: Pharmacol Ther. 2007 Feb;113(2):264-75
references: 17056121
references: Bioorg Med Chem. 2010 Mar 15;18(6):2195-2203
references: 20188574
references: Purinergic Signal. 2009 Mar;5(1):51-61
references: 18615273
references: Trends Pharmacol Sci. 1998 May;19(5):184-91
references: 9652191
references: Drug Discov Today. 1999 Dec;4(12):542-551
references: 10557136
references: Curr Med Chem. 2006;13(30):3609-25
references: 17168726
references: Pharmacol Ther. 2008 Dec;120(3):233-53
references: 18848843
references: Bioorg Med Chem. 2007 Feb 15;15(4):1586-605
references: 17197188